Pacific Biosciences of California Inc (NASDAQ:PACB)
| 2.79 Data as of 1:16pm ET |  -0.01 / -0.36%Today’s Change | 1.06 Today|||52-Week Range 3.25 | +64.12% Year-to-Date |
Latest PACB News | Press Releases
| Commit To Purchase Pacific Biosciences California At $2.50, Earn 35.1% Annualized Jun 17 / TheStreet.com | 2 Stocks to Buy, 1 to Hold Jun 06 / MotleyFool.com |
Today’s Trading
| Previous close | 2.80 |
| Today’s open | 2.78 |
| Day’s range | 2.77 - 2.85 |
| Volume | 82,737 |
| Average volume (3 months) | 383,471 |
| Market cap | $185.7M |
| Dividend yield | -- |
Data as of 1:16pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +16.75% |
| Earnings growth (this year) | +20.71% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -23.27% |
| P/E ratio | NM |
| Price/Sales | 3.65 |
| Price/Book | 1.44 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PSTIPluristem Therapeuti... | -0.09 | -3.23% |
| SIGASIGA Technologies In... | -0.03 | -0.96% |
| NSPHNanosphere Inc | +0.02 | +0.68% |
| BTXBioTime Inc | +0.08 | +1.98% |
Data as of 1:28pm ET, 06/19/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $26.0M |
| Annual profit (last year) | -$94.5M |
| Net profit margin | -363.56% |
Profile
Sector Health Technology |
Industry Biotechnology |
Executive Chairman, President & CEO Mike W. Hunkapiller, PhD |
Chief Financial Officer & Executive Vice President Susan K. Barnes, MBA |
Corporate headquarters Menlo Park, California |
Forecasts
